DE69118130T2 - Nahrung - Google Patents

Nahrung

Info

Publication number
DE69118130T2
DE69118130T2 DE69118130T DE69118130T DE69118130T2 DE 69118130 T2 DE69118130 T2 DE 69118130T2 DE 69118130 T DE69118130 T DE 69118130T DE 69118130 T DE69118130 T DE 69118130T DE 69118130 T2 DE69118130 T2 DE 69118130T2
Authority
DE
Germany
Prior art keywords
parenteral
compositions
food
enteral
efas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69118130T
Other languages
English (en)
Other versions
DE69118130D1 (de
Inventor
David F Horrobin
Lars Lindmark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Publication of DE69118130D1 publication Critical patent/DE69118130D1/de
Application granted granted Critical
Publication of DE69118130T2 publication Critical patent/DE69118130T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pediatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69118130T 1990-12-07 1991-12-04 Nahrung Expired - Fee Related DE69118130T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909026648A GB9026648D0 (en) 1990-12-07 1990-12-07 Nutrition

Publications (2)

Publication Number Publication Date
DE69118130D1 DE69118130D1 (de) 1996-04-25
DE69118130T2 true DE69118130T2 (de) 1996-10-02

Family

ID=10686652

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69118130T Expired - Fee Related DE69118130T2 (de) 1990-12-07 1991-12-04 Nahrung

Country Status (13)

Country Link
EP (2) EP0490561B1 (de)
JP (1) JPH04290821A (de)
AT (1) ATE135535T1 (de)
AU (1) AU652785B2 (de)
CA (1) CA2056957A1 (de)
DE (1) DE69118130T2 (de)
DK (1) DK0490561T3 (de)
ES (1) ES2084787T3 (de)
GB (1) GB9026648D0 (de)
GR (1) GR3020173T3 (de)
IE (1) IE72221B1 (de)
NZ (1) NZ240841A (de)
ZA (1) ZA919571B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308832A (en) * 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
EP0711503A3 (de) * 1994-11-14 1997-11-26 Scotia Holdings Plc Mit GLA und/oder DGLA angereicherte Milch
GB9617847D0 (en) 1996-08-27 1996-10-09 Scotia Holdings Plc Fatty acid treatment
JP2001514667A (ja) * 1997-03-17 2001-09-11 タム，ユン ケー． 肝臓脂肪症の予防のための組成物
JP4129566B2 (ja) 1997-09-05 2008-08-06 大塚製薬株式会社 肝臓脂肪蓄積抑制組成物及び肝臓脂肪蓄積抑制用食品添加剤
DE19757414A1 (de) * 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
GB9923738D0 (en) 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
US7981915B2 (en) 2003-04-30 2011-07-19 Beth Israel Deaconess Medical Center Methods for modulating PPAR biological activity for the treatment of diseases caused by mutations in the CFTR gene
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
EP1660071A1 (de) 2003-08-18 2006-05-31 Btg International Limited Behandlung von neurodegenerativen erkrankungen
GB0504362D0 (en) 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
JP5341749B2 (ja) * 2007-03-30 2013-11-13 興和株式会社 脂肪肝又は非アルコール性脂肪性肝炎の予防及び／又は治療のための医薬
WO2009060452A2 (en) * 2007-11-08 2009-05-14 Galmed International Ltd. Methods and compositions for treating biliary cholesterol crystallization and related conditions
EP4039326A4 (de) * 2019-10-01 2023-08-02 Suntory Holdings Limited Zusammensetzung zur verbesserung der darmfunktion durch expressionskontrolle von aquaporin 3 und ihre verwendung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56122312A (en) * 1980-02-29 1981-09-25 Kagakuhin Kensa Kyokai Hepatic cholesterol-lowering agent (hepatic decholesterolizing agent)
GB8319073D0 (en) * 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
JPS60169418A (ja) * 1984-02-15 1985-09-02 Nippon Oil & Fats Co Ltd 胆石症の予防および治療剤
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
DE3785667T2 (de) * 1986-09-17 1994-07-21 Clintec Nutrition Co Zusatznahrung bzw. therapie für personen mit risiko oder in behandlung für arteriosklerotische vaskuläre, kardiovaskuläre und/oder thrombotische erkrankungen.
SE8604117D0 (sv) * 1986-09-29 1986-09-29 Kabivitrum Ab Composition
JPS63297342A (ja) * 1987-05-28 1988-12-05 Nisshin Oil Mills Ltd:The 合成油脂ならびにこれを含有する脂肪乳剤輸液および経腸栄養剤
DE3721137A1 (de) * 1987-06-26 1989-01-05 Dietl Hans Fettemulsion zur intravenoesen anwendung
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions

Also Published As

Publication number Publication date
NZ240841A (en) 1997-07-27
IE72221B1 (en) 1997-04-09
AU8839791A (en) 1992-06-11
EP0490561A2 (de) 1992-06-17
ZA919571B (en) 1992-11-25
AU652785B2 (en) 1994-09-08
ATE135535T1 (de) 1996-04-15
EP0682878A3 (de) 1998-01-14
ES2084787T3 (es) 1996-05-16
DK0490561T3 (da) 1996-04-15
DE69118130D1 (de) 1996-04-25
GR3020173T3 (en) 1996-09-30
EP0682878A2 (de) 1995-11-22
IE914174A1 (en) 1992-06-17
GB9026648D0 (en) 1991-01-23
JPH04290821A (ja) 1992-10-15
EP0490561A3 (en) 1992-10-07
EP0490561B1 (de) 1996-03-20
CA2056957A1 (en) 1992-06-08

Similar Documents

Publication Publication Date Title
EP0568606A4 (de)
DE69118130D1 (de) Nahrung
ATE142435T1 (de) Nahrhafte zusammensetzung
RU93052410A (ru) Композиции, содержащие смеси микробных масел, пищевые добавки, добавки к питательной смеси для младенцев, способ их применения
PH25552A (en) Composition containing novel solid nondigestible fat-like compound
DE3887247T2 (de) Feste unverdauliche fettähnliche Verbindungen.
DK0526526T3 (da) Hidtil ukendte faste, ikke-fordøjelige, fedtstoflignende forbindelser og levnedsmiddelsammensætninger indeholdende samme

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee